Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial

BACKGROUND: Recently, a new coronavirus spreads rapidly throughout the countries and resulted in a worldwide epidemic. Interferons have direct antiviral and immunomodulatory effects. Antiviral effects may include inhibition of viral replication, protein synthesis, virus maturation, or virus release...

Descripción completa

Detalles Bibliográficos
Autores principales: Dastan, Farzaneh, Nadji, Seyed Alireza, Saffaei, Ali, Marjani, Majid, Moniri, Afshin, Jamaati, Hamidreza, Hashemian, Seyed MohammadReza, Baghaei, Parvaneh, Abedini, Atefeh, Varahram, Mohammad, Yousefian, Sahar, Tabarsi, Payam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275997/
https://www.ncbi.nlm.nih.gov/pubmed/32544867
http://dx.doi.org/10.1016/j.intimp.2020.106688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275997/
https://www.ncbi.nlm.nih.gov/pubmed/32544867
http://dx.doi.org/10.1016/j.intimp.2020.106688

Ejemplares similares